DarioHealth (NASDAQ:DRIO) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of DarioHealth (NASDAQ:DRIO) from a sell rating to a hold rating in a research report released on Sunday morning.

Several other brokerages have also recently weighed in on DRIO. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DarioHealth in a research note on Wednesday, October 8th. Cowen reaffirmed a “hold” rating on shares of DarioHealth in a research report on Friday, November 14th. Finally, Stifel Nicolaus set a $16.00 price target on shares of DarioHealth in a research note on Friday, November 14th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $32.00.

DarioHealth Stock Up 0.7%

NASDAQ DRIO opened at $10.14 on Friday. DarioHealth has a 1 year low of $5.93 and a 1 year high of $31.00. The stock has a market capitalization of $68.63 million, a PE ratio of -0.91 and a beta of 1.08. The company has a debt-to-equity ratio of 0.41, a current ratio of 4.55 and a quick ratio of 4.02. The business’s 50-day moving average is $12.88 and its 200 day moving average is $12.36.

Institutional Investors Weigh In On DarioHealth

A hedge fund recently raised its stake in DarioHealth stock. XTX Topco Ltd lifted its holdings in DarioHealth Corp. (NASDAQ:DRIO) by 229.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,511 shares of the company’s stock after acquiring an additional 43,513 shares during the period. XTX Topco Ltd owned 0.14% of DarioHealth worth $42,000 at the end of the most recent reporting period. Institutional investors own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.